From Astrazenecadec News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from From Astrazenecadec. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In From Astrazenecadec Today - Breaking & Trending Today

Forxiga (dapagliflozin) approved for symptomatic chronic heat failure

Published: December 12, 2022

AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a licence extension for dapagliflozin in Great Britain for the treatment of symptomatic chronic heart failure (HF) in patients with HF and a left ventricular ejection fraction (LVEF)

Source: news-medical.net

Related Topics:

United KingdomCity OfGreat BritainJohn McmurrayPied PiperAstrazeneca United Kingdom LtdInstitute Of CardiovascularUniversity Of GlasgowRegulatory AgencyCardiovascular Research CentreBritish Heart FoundationScientific AffairsOffice For National StatisticsFrom AstrazenecadecMedical SciencesScientific Affairs DirectorAstrazeneca United KingdomMedicines CompendiumProduct CharacteristicsHeart FailureMildly ReducedPreserved EjectionZeneca United KingdomNational StatisticsMid Year Population Estimates